Dr Louise Causer is a medical epidemiologist and Senior Lecturer at the Kirby Institute. Her research focuses on the implementation and evaluation of infectious diseases point-of-care diagnostics. Louise currently co-leads the National STI (TTANGO) POCT program and is also involved in the Respiratory Infections and HCV POCT programs.

Dr Louise Causer is a medical epidemiologist and Senior Lecturer at the Kirby Institute. Her research focuses on the implementation and evaluation of infectious diseases point-of-care diagnostics. Louise currently co-leads the National STI (TTANGO) POCT program and is also involved in the Respiratory Infections and HCV POCT programs.

Dr Richard Gray is a Senior Research Fellow in the Surveillance, Evaluation and Research Program at the Kirby Institute. He leads the Mathematical Epidemiology and Evaluation Research Group and has extensive experience designing, implementing, and analysing models of the transmission of HIV, viral hepatitis, other sexually transmitted infections (STIs), SARS-CoV-2, and arboviruses. Richard has collaborated with social researchers, epidemiologists, clinicians and public health workers to develop numerous complex models to understand the trajectories of epidemics and evaluate the potential impact of public health strategies in Australia, Papua New Guinea (PNG), across Asia, Eastern Europe and Africa. Richard led the modelling of DAA treatment roll-out for HCV to inform the coverage required to meet the WHO HCV elimination targets. He also conducted mathematical modelling to assess the cost-effectiveness of PrEP for HIV prevention in Australian gay men. Based on this analysis, among other matters, the Pharmaceutical Benefits Advisory Committee recommended the listing of HIV PrEP onto the Pharmaceutical Benefits Scheme. Richard is responsible for producing annual estimates of Australia’s diagnosis and care cascades for HIV, viral hepatitis, and other STIs in the reported in the HIV, viral hepatitis and sexually transmissible infections for national surveillance. In the past he has completed projects for Australian departments of health, key Australian community organizations, WHO, UNAIDS, and the World Bank. He regularly provides estimates of HIV epidemiology, burden, and program costs to the Australian Department of Health and the key community organizations to inform policy development.

Rosanna Peeling is Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine, Director of the International Diagnostic Centre (IDC) and Professor at the Department of Medical Microbiology at the University of Manitoba, Canada. Trained as a medical microbiologist, she previously held positions as the Chief of the Canadian National Laboratory for Sexually Transmitted Diseases, and Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases in Geneva. Her research focuses on defining unmet diagnostic needs and facilitating test development, evaluation and implementation. She established the IDC to advocate the value of diagnostics, foster innovation, and accelerate access to quality-assured diagnostics. She has served on WHO guideline development groups for HIV, Hepatitis, dengue and as a member of many expert advisory committees, including the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD), the Global Validation Advisory Committee for the Elimination of Mother-to-child Transmission of HIV, Syphilis and Hepatitis B, the Global Antimicrobial Resistance (AMR) Innovation Fund, the European Horizon 2020 and UK Longitude Prize for AMR, the US National Academies of Science, Engineering and Medicine’s Committee on Public Health Interventions and Countermeasures for Advancing Pandemic and Seasonal Influenza Preparedness and Response, the G20 Summit Task Force advisory group and the Africa CDC Laboratory Working Group. Prof Peeling was awarded the Royal Society of Tropical Medicine and Hygiene’s George MacDonald Medal for outstanding contribution to tropical medicine in 2014 and made an Honorary Fellow of the Society in 2021.

Sanjay Sarin joined FIND in September 2015 as Head of Country Operations for India and Head of Access Programme for Asia Pacific. He has a doctorate from PGIMER, Chandigarh, India and close to 20 years’ experience in health policy, market development, and business management with specialization in the development of strategic initiatives for driving access in emerging markets. In his current role, he is responsible for providing leadership for strategic plan development and implementation of current and planned operations in FIND India, ensuring continued engagement with partners and donors at local and international levels and leading the resource mobilization efforts in the AP region. Sanjay joined FIND from Becton Dickinson (BD), where he was Regional Director of Global Health for the Asia Pacific region and was responsible for design, development, and implementation of BD’s public health strategies. During his stint with BD, he was instrumental in establishing several key partnerships, including one with MoH India, which resulted in expansion of TB diagnostic capacity within the national TB programme; TB lab strengthening partnership with USAID in Indonesia; collaboration with Project Hope to strengthen diabetes management capacity at Class 1 facilities in China, and a lab systems strengthening partnership with CDC and MoH India known as the “Labs for Life Partnership”. Before joining BD, Sanjay served as Regional Lab Advisor (India & South East Asia) with the Clinton Health Access Initiative (CHAI). In CHAI, he played a key role in scaling up access to CD4 monitoring within India’s AIDS Control Programme and was responsible for setting up more than a dozen functional CD4 laboratories, development of the CD4 enumeration guidelines and an external quality assurance system for CD4 monitoring in India.